- Home
- TUP vs TARA Comparison
TUP vs TARA Comparison
Compare TUP & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUP
- TARA
- Stock Information
- Founded
- TUP 1946
- TARA N/A
- Country
- TUP United States
- TARA United States
- Employees
- TUP N/A
- TARA N/A
- Industry
- TUP Plastic Products
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TUP Industrials
- TARA Health Care
- Exchange
- TUP Nasdaq
- TARA Nasdaq
- Market Cap
- TUP 53.5M
- TARA 41.3M
- IPO Year
- TUP 1996
- TARA N/A
- Fundamental
- Price
- TUP $1.16
- TARA $1.86
- Analyst Decision
- TUP
- TARA Strong Buy
- Analyst Count
- TUP 0
- TARA 2
- Target Price
- TUP N/A
- TARA $24.00
- AVG Volume (30 Days)
- TUP 363.2K
- TARA 189.1K
- Earning Date
- TUP 09-17-2024
- TARA 11-01-2024
- Dividend Yield
- TUP N/A
- TARA N/A
- EPS Growth
- TUP N/A
- TARA N/A
- EPS
- TUP N/A
- TARA N/A
- Revenue
- TUP $1,141,900,000.00
- TARA N/A
- Revenue This Year
- TUP N/A
- TARA N/A
- Revenue Next Year
- TUP $3.27
- TARA N/A
- P/E Ratio
- TUP N/A
- TARA N/A
- Revenue Growth
- TUP N/A
- TARA N/A
- 52 Week Low
- TUP $0.93
- TARA $1.04
- 52 Week High
- TUP $2.72
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- TUP 43.04
- TARA 34.85
- Support Level
- TUP $1.16
- TARA $1.86
- Resistance Level
- TUP $1.26
- TARA $2.04
- Average True Range (ATR)
- TUP 0.06
- TARA 0.15
- MACD
- TUP 0.00
- TARA -0.01
- Stochastic Oscillator
- TUP 15.79
- TARA 9.18
About TUP Tupperware Brands Corporation
Tupperware Brands Corp is a consumer products company that designs innovative, functional, and environmentally responsible products. The company distributes its products into nearly 70 countries. The company engages in the marketing, manufacture, and sale of design-centric preparation, storage, and serving solutions for the kitchen and home through the Tupperware brand name. The company primarily uses a direct selling business model to distribute and market products, while continuing to expand digital platforms and business-to-business distribution channels. The company operates its business under four reportable segments in four broad geographic regions namely the Asia Pacific, Europe (Europe, Africa and the Middle East), North America, and South America.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).